Where Innovation Meets Collaboration
Building Better Together
At COEUS Healthcare, we believe the most impactful solutions are created when visionary ideas and cutting-edge technology come together. Our partnership program empowers organizations to integrate with our platform, unlock new capabilities, and deliver greater value to customers. By combining our strengths, we can accelerate innovation, expand market reach, and shape the future of biotech —together.
Prime Therapeutics and COEUS Healthcare have come together in a strategic partnership to unlock the full potential of value-based care for Medicaid patients. Together, Prime and COEUS are addressing one of the most pressing needs in healthcare: enabling innovative therapies to reach patients faster, while ensuring that reimbursement is tied to real-world outcomes.
COEBRA™ serves as the trusted, neutral third party to manage clinical policy verification, track claims performance, reconcile invoices, and generate actionable real-world evidence across stakeholders. As a neutral third party, COEUS Healthcare receives a fixed fee from both the manufacturer and Prime to enable real-time adjudication of value-based contract.
Prime-CHC Partnership:
This partnership enables:
-
Operational Excellence – Automation of complex contracting workflows, payer onboarding, and outcomes adjudication across Prime’s extensive payer network.
-
Transparency and Trust – Secure ingestion and analysis of payer claims data via a SOC-2 and HITRUST-certified infrastructure, ensuring compliance and neutrality.
-
Scalable Impact – Real-time visibility into contract performance, enabling timely insights, risk mitigation, and expanded patient access to high-cost, high-impact therapies.
Whether piloting a new warranty contract, implementing outcomes-based agreements for gene therapies, or scaling a multi-payer VBA, the Prime–COEUS partnership offers unmatched technical infrastructure, operational support, and strategic insight.
Delivering value at scale. Enabling precision access. Transforming how healthcare pays for outcomes.
Red Nucleus and COEUS Healthcare have formed a strong partnership to help biopharma manufacturers bring innovative, value-based contracts (VBCs) to life — from strategic design to operational execution.
With Red Nucleus’ deep consulting expertise in market access, pricing, HEOR, and evidence generation, and COEUS’ best-in-class COEBRA™ platform for VBC implementation and adjudication, manufacturers now have access to a fully integrated solution that ensures their contracts are both strategically sound and operationally scalable.
Let us help you move from “concept” to “contract live” — and ensure your innovative therapy delivers measurable value to the healthcare system.
Red Nucleus Partnership:
What We Offer — Together
-
Strategic Contract Design
Red Nucleus supports manufacturers in identifying the right value metrics, contract models (e.g., warranty, outcomes-based), and engagement strategies across payer and provider segments.
-
Evidence and Insights Development
End-to-end support on evidence strategy, patient outcomes selection, and feasibility assessments — aligned to therapeutic value and real-world impact.
-
Platform-Driven Execution and Scaling
COEBRA™ provides the secure, compliant, and fully automated infrastructure to ingest payer data, evaluate outcomes, reconcile invoices, and generate actionable RWE.
-
Neutral, Trusted Infrastructure
COEBRA acts as the independent adjudicator — trusted by both manufacturers and payers to deliver transparent, bias-free contract performance reporting.
VBCs are complex. With Red Nucleus and COEBRA, they don’t have to be.